125 related articles for article (PubMed ID: 35255270)
1. Ayurveda panchakarma treatment success in a case of chronic spontaneous urticaria non-responding to conventional medicine-A case study.
S KR; Panda AK; P B; Kar BR; S I
J Ayurveda Integr Med; 2022; 13(2):100549. PubMed ID: 35255270
[TBL] [Abstract][Full Text] [Related]
2. Management of Chronic Spontaneous Urticaria Unresponsive to Conventional Treatment Through a Course of Panchakarma Therapies: A Case Report.
Dharmarajan P; Dahiya A; Therokar S; S AY
Altern Ther Health Med; 2024 May; ():. PubMed ID: 38819189
[TBL] [Abstract][Full Text] [Related]
3. The impact of omalizumab on quality of life and its predictors in patients with chronic spontaneous urticaria: Real-life data.
Salman A; Demir G; Bekiroglu N
Dermatol Ther; 2019 Jul; 32(4):e12975. PubMed ID: 31145524
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and management of chronic spontaneous urticaria in patients refractory to H
Chu CY; Al Hammadi A; Agmon-Levin N; Atakan N; Farag A; Arnaout RK; Kannenberg S; Kulthanan K; Mubarak A; Zaitoun F; Crowe S; Malfait S; Cooke K; Dekker EL
World Allergy Organ J; 2020 Apr; 13(4):100117. PubMed ID: 32382379
[TBL] [Abstract][Full Text] [Related]
5. Improvement in the quality of life of patients with chronic spontaneous urticaria treated with omalizumab in real life.
Larrea-Baca I; Gurpegui-Resano M
Enferm Clin; 2017; 27(6):361-368. PubMed ID: 28457893
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of omalizumab in chronic spontaneous urticaria assessed with patient-reported outcomes: a prospective study.
Ghazanfar MN; Holm JG; Thomsen SF
J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1761-1767. PubMed ID: 29729103
[TBL] [Abstract][Full Text] [Related]
7. Omalizumab in patients with chronic spontaneous urticaria nonresponsive to H1-antihistamine treatment: results of the phase IV open-label SUNRISE study.
Bérard F; Ferrier Le Bouedec MC; Bouillet L; Reguiai Z; Barbaud A; Cambazard F; Milpied B; Pelvet B; Kasujee I; Gharbi H; Lacour JP
Br J Dermatol; 2019 Jan; 180(1):56-66. PubMed ID: 29927483
[TBL] [Abstract][Full Text] [Related]
8. Socio-economic burden and resource utilisation in Italian patients with chronic urticaria: 2-year data from the AWARE study.
Rossi O; Piccirillo A; Iemoli E; Patrizi A; Stingeni L; Calvieri S; Gola M; Dapavo P; Cristaudo A; Zichichi L; Losappio L; Saccheri F; Pastorello EA
World Allergy Organ J; 2020 Dec; 13(12):100470. PubMed ID: 33343800
[TBL] [Abstract][Full Text] [Related]
9. Validity and responsiveness of the Urticaria Activity and Impact Measure: A new patient-reported tool.
Maurer M; Mathias SD; Crosby RD; Rajput Y; Zazzali JL
Ann Allergy Asthma Immunol; 2018 Jun; 120(6):641-647. PubMed ID: 29567359
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of Autologous Whole-Blood Injections in Patients with Refractory Chronic Spontaneous Urticaria.
Kitsioulis NA; Xepapadaki P; Roussaki-Schulze AV; Papadopoulos N; Zafiriou E
Int Arch Allergy Immunol; 2017; 172(3):161-166. PubMed ID: 28380487
[TBL] [Abstract][Full Text] [Related]
11. The Arabic Urticaria Activity Score and Chronic Urticaria Quality of Life Questionnaire: validation and correlations.
Tawil S; Irani C; Kfoury R; Salameh P; Baiardini I; Weller K; Maurer M; Ezzedine K
Int J Dermatol; 2020 Aug; 59(8):893-901. PubMed ID: 32638368
[TBL] [Abstract][Full Text] [Related]
12. Omalizumab in chronic spontaneous urticaria: Efficacy, safety, predictors of treatment outcome, and time to response.
Nettis E; Cegolon L; Di Leo E; Lodi Rizzini F; Detoraki A; Canonica GW;
Ann Allergy Asthma Immunol; 2018 Oct; 121(4):474-478. PubMed ID: 29949781
[TBL] [Abstract][Full Text] [Related]
13. Psychometric properties of the Spanish version of the once-daily Urticaria Activity Score (UAS) in patients with chronic spontaneous urticaria managed in clinical practice (the EVALUAS study).
Jauregui I; Gimenez-Arnau A; Bartra J; Labrador-Horrillo M; de Frutos JO; Silvestre JF; Sastre J; Velasco M; Ferrer M; Ballesteros C; Valero A
Health Qual Life Outcomes; 2019 Jan; 17(1):23. PubMed ID: 30704532
[TBL] [Abstract][Full Text] [Related]
14. Probiotic as an adjuvant therapy in chronic urticaria: a blinded randomized controlled clinical trial.
Atefi N; Fallahpour M; Sharifi S; Ghassemi M; Roohaninasab M; Goodarzi A
Eur Ann Allergy Clin Immunol; 2022 May; 54(3):123-130. PubMed ID: 33939347
[No Abstract] [Full Text] [Related]
15. Effect of omalizumab on angioedema in H1 -antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial.
Staubach P; Metz M; Chapman-Rothe N; Sieder C; Bräutigam M; Canvin J; Maurer M
Allergy; 2016 Aug; 71(8):1135-44. PubMed ID: 27010957
[TBL] [Abstract][Full Text] [Related]
16. Chronic urticaria treatment patterns and changes in quality of life: AWARE study 2-year results.
Maurer M; Giménez-Arnau A; Ensina LF; Chu CY; Jaumont X; Tassinari P
World Allergy Organ J; 2020 Sep; 13(9):100460. PubMed ID: 32983330
[TBL] [Abstract][Full Text] [Related]
17. Omalizumab in elderly patients with chronic spontaneous urticaria: An Italian real-life experience.
Nettis E; Cegolon L; Di Leo E; Canonica WG; Detoraki A;
Ann Allergy Asthma Immunol; 2018 Mar; 120(3):318-323. PubMed ID: 29508719
[TBL] [Abstract][Full Text] [Related]
18. Antihistamine-resistant chronic spontaneous urticaria: 1-year data from the AWARE study.
Maurer M; Raap U; Staubach P; Richter-Huhn G; Bauer A; Oppel EM; Hillen U; Baeumer D; Reinhardt M; Chapman-Rothe N
Clin Exp Allergy; 2019 May; 49(5):655-662. PubMed ID: 30415478
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Chronic Spontaneous Urticaria with a Single Dose of Omalizumab: A Study of Four Cases.
Subramaniyan R; Chopra A
Indian J Dermatol; 2016; 61(4):467. PubMed ID: 27512204
[TBL] [Abstract][Full Text] [Related]
20. Omalizumab in Chronic Spontaneous Urticaria Refractory to Conventional Therapy: An Italian Retrospective Clinical Analysis with Suggestions for Long-Term Maintenance Strategies.
Mandel VD; Guanti MB; Liberati S; Demonte A; Pellacani G; Pepe P
Dermatol Ther (Heidelb); 2018 Jun; 8(2):291-301. PubMed ID: 29770909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
